Connection
Daniel Pollyea to United States Food and Drug Administration
This is a "connection" page, showing publications Daniel Pollyea has written about United States Food and Drug Administration.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.347 |
|
|
|
-
Pollyea DA, Barrett J, DiNardo CD, Michaelis LC, Roboz GJ, Le RQ, Norsworthy KJ, de Claro RA, Theoret MR, Pazdur R. Project 2025: Proposals for the Continued Success of Drug Development in Acute Myeloid Leukemia. Clin Cancer Res. 2022 03 01; 28(5):816-820.
Score: 0.174
-
DiNardo CD, Pollyea DA. Beyond Survival: The US Food and Drug Administration Confirms Surrogate End Points for Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Intensive Chemotherapy. J Clin Oncol. 2022 03 10; 40(8):811-813.
Score: 0.173